MILLENNIUM MANAGEMENT LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1273087 NEW YORK, NY

Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$33,947,290

+$32,160,187 QoQ

Shares Held

3,394,729

+1708.4% QoQ

Ownership

1.33%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#19

of 316 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Derivatives in BCRX

reported options exposure · as of Mar 31, 2026

CallValue

$1,237,600

CallShares

130,000

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MILLENNIUM MANAGEMENT LLC holds $1,140,219,030 across 49 Drug Manufacturers - Specialty & Generic names. BCRX ranks #9 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	409,074	$221,648,565
2	SUPN	Supernus Pharmaceuticals, Inc.	3,853,212	$179,212,890
3	ZTS	Zoetis Inc.	1,813,759	$130,336,721
4	TEVA	Teva Pharmaceutical Industries Ltd	3,265,321	$110,629,075
5	INDV	Indivior Pharmaceuticals, Inc.	2,098,945	$86,119,713
6	ELAN	Elanco Animal Health Inc	2,725,889	$67,084,128
7	ANIP	Ani Pharmaceuticals Inc	507,207	$41,986,595
8	LNTH	Lantheus Holdings, Inc.	336,399	$37,320,105

All Filings in BCRX

Export CSV

38 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$33,947,290	3,394,729	+1708.4%	Shares	Sole	2026-08-14
2026-03-31	$1,787,103	187,721	+36.4%	Shares	Sole	2026-05-15
2026-03-31	$1,237,600	130,000	+30.0%	Call	Sole	2026-05-15
2025-12-31	$1,073,482	137,626	-70.1%	Shares	Sole	2026-02-17
2025-09-30	$3,498,587	460,947	-75.8%	Shares	Sole	2025-11-14
2025-06-30	$896,000	100,000	-1.3%	Call	Sole	2025-08-14
2025-06-30	$17,083,736	1,906,667	-50.0%	Shares	Sole	2025-08-14
2025-03-31	$28,596,555	3,812,874	+382.6%	Shares	Sole	2025-05-15
2024-12-31	$5,941,589	790,105	-40.3%	Shares	Sole	2025-02-14
2024-09-30	$10,054,040	1,322,900	-24.5%	Shares	Sole	2024-11-14
2024-09-30	$769,880	101,300	-49.7%	Call	Sole	2024-11-14
2024-06-30	$10,824,646	1,751,561	-4.3%	Shares	Sole	2024-08-14
2024-03-31	$9,297,258	1,830,169	+9.2%	Shares	Sole	2024-05-15
2024-03-31	$1,022,096	201,200	-66.0%	Call	Sole	2024-05-15
2023-12-31	$10,040,330	1,676,182	-66.4%	Shares	Sole	2024-02-14
2023-12-31	$3,544,882	591,800	+294.0%	Call	Sole	2024-02-14
2023-09-30	$35,281,105	4,983,207	-6.0%	Shares	Sole	2023-11-14
2023-09-30	$1,063,416	150,200	+48.9%	Call	Sole	2023-11-14
2023-06-30	$37,326,220	5,302,020	+19.5%	Shares	Sole	2023-08-14
2023-06-30	$710,336	100,900	-57.8%	Call	Sole	2023-08-14
2023-03-31	$473,712	56,800	—	Put	Sole	2023-05-15
2023-03-31	$37,007,323	4,437,329	+28000.4%	Shares	Sole	2023-05-15
2023-03-31	$1,995,762	239,300	+137.6%	Call	Sole	2023-05-15
2022-12-31	$1,156,036	100,700	+151.8%	Call	Sole	2023-02-14
2022-12-31	$181,280	15,791	-98.8%	Shares	Sole	2023-02-14
2022-09-30	$16,713,169	1,326,442	-31.9%	Shares	Sole	2022-11-14
2022-06-30	$20,616,135	1,948,595	+3445.8%	Shares	Sole	2022-08-15
2022-03-31	$893,568	54,955	-52.6%	Shares	Sole	2022-05-16
2021-12-31	$1,604,300	115,834	-72.5%	Shares	Sole	2022-02-14
2021-09-30	$6,062,027	421,853	-41.0%	Shares	Sole	2021-11-15
2021-06-30	$11,306,363	715,140	+149.5%	Shares	Sole	2021-08-16
2021-03-31	$406,800	40,000	-93.8%	Call	Sole	2021-05-17
2020-12-31	$2,135,408	286,632	-91.6%	Shares	Sole	2021-02-16
2020-09-30	$11,675,057	3,393,912	-48.3%	Shares	Sole	2020-11-16
2020-06-30	$31,251,975	6,565,541	+1.8%	Shares	Sole	2020-08-14
2020-06-30	$3,094,000	650,000	+469.7%	Call	Sole	2020-08-14
2020-03-31	$228,200	114,100	—	Call	Sole	2020-05-14
2020-03-31	$12,904,682	6,452,341	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.